Literature DB >> 15945350

[Effect of the pharmacological agent hesperadin on breast and prostate tumor cultured cells].

N G Ladygina, R V Latsis, T Yen.   

Abstract

Aurora B, which is important for cell division control, is highly expressed in large number of cancer cell lines. Hesperadin, a prototype of a pharmacological agent, is a small molecule inhibitor of catalytic activity of Aurora B. In present work we investigate effect of Hesperadin on breast--MCF7 and prostate adenocarcinoma--PC3, cancer cell lines. After Hesperadin treatment we observe stop of cell proliferation due to appearance of multiple mitotic defects caused by Aurora B activity reduction and elimination of checkpoint proteins--such as hBUBR1 and CENP-E--from kinetochores of mitotic chromosomes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15945350

Source DB:  PubMed          Journal:  Biomed Khim        ISSN: 2310-6905


  3 in total

Review 1.  The Aurora kinase inhibitors in cancer research and therapy.

Authors:  Jonas Cicenas
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-01       Impact factor: 4.553

2.  Synthesis and investigation of new Hesperadin analogues antitumor effects on HeLa cells.

Authors:  Fereshteh Shamsipour; Saeeideh Hosseinzadeh; Seyed Shahriar Arab; Sedigheh Vafaei; Samira Farid; Mahmood Jeddi-Tehrani; Saeed Balalaie
Journal:  J Chem Biol       Date:  2014-05-18

3.  MST4 Kinase Inhibitor Hesperadin Attenuates Autophagy and Behavioral Disorder via the MST4/AKT Pathway in Intracerebral Hemorrhage Mice.

Authors:  Xiaodong Wu; Jinting Wu; Wenjie Hu; Qinghua Wang; Hairong Liu; Zhaohu Chu; Kun Lv; Yang Xu
Journal:  Behav Neurol       Date:  2020-02-03       Impact factor: 3.342

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.